(Q36618888)

15 August 2017

The influence on survival of delay in the presentation and treatment of symptomatic breast cancer (English)

1 reference

15 August 2017

1 reference

Richards MA

1

1 reference

15 August 2017

Smith P

2

1 reference

15 August 2017

Ramirez AJ

3

1 reference

15 August 2017

Fentiman IS

4

1 reference

15 August 2017

Rubens RD

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

79

1 reference

15 August 2017

5-6

1 reference

15 August 2017

858-864

1 reference

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Who and what influences delayed presentation in breast cancer?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Primary invasive breast carcinoma in Oslo 1980-1989. Incidence and delay

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Medicolegal analysis of the delayed diagnosis of cancer in 338 cases in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

The Relative Significance of Prognostic Factors in Breast Carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Patient's and doctor's delay in primary breast cancer. Prognostic implications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Prognosis in inoperable stage III carcinoma of the breast

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Delay, stage of disease and survival from breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362673

Malaria resistant to chloroquine and sulphamethoxine-pyrimethamine

28 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690137

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690137

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690137

The effects of delay in treatment of survival rates in carcinoma of the breast

21 January 2018

1 reference

12 December 2020

Breast self-examination and survival from breast cancer

1 reference

12 December 2020

Prognostic Factors in Mammary Carcinoma

1 reference

12 December 2020

A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer

1 reference

12 December 2020

Combined chemotherapy and radiotherapy for locally advanced breast cancer

1 reference

12 December 2020

Delay in diagnosis and long-term survival in breast cancer

1 reference

12 December 2020

Delay in breast cancer and the nature of presenting symptoms

1 reference

12 December 2020

The effects of patient delay and symptoms other than a lump on survival in breast cancer

1 reference

12 December 2020

Relation between delay and survival in 596 patients with breast cancer

1 reference

12 December 2020

Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792)

1 reference

12 December 2020

Does delay in diagnosis of breast cancer affect survival?

1 reference

12 December 2020

Diagnostic delay in breast cancer: correlation with disease stage and prognosis

1 reference

12 December 2020

Delay in the treatment of carcinoma of the breast

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6690137

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

10070881

1 reference